Clinical Trial Update: Open-Trial of EPI-743 for Adults With Tourette Syndrome [Phase 1]

View source ↗

Summary

Phase 1 open-trial of EPI-743 for adults with Tourette syndrome completed. The trial was sponsored by Yale University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tourette Syndrome

Drugs mentioned

• EPI-743

Snippet

Sponsor: Yale University | Conditions: Tourette Syndrome | Phase 1 | Status: COMPLETED